Evidence map›Paper›PMID 12805458›Full record

ArticleJournal of virology2003

Nuclear export of Vpr is required for efficient replication of human immunodeficiency virus type 1 in tissue macrophages.

Michael P Sherman, Carlos M C de Noronha, Lauren A Eckstein, Jason Hataye, Pamela Mundt, Samuel A F Williams, Jason A Neidleman, Mark A Goldsmith, Warner C Greene

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. HIV-1 Vpr-a still "enigmatic multitasker".Frontiers in microbiology · 2014
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Michael P ShermanGladstone Institute of Virology and Immunology, San Francisco, California 94141, USA.
Carlos M C de Noronha
Lauren A Eckstein
Jason Hataye
Pamela Mundt
Samuel A F Williams
Jason A Neidleman
Mark A Goldsmith
Warner C Greene
Institute of Virology of the Slovak Academy of Sciences · SKUniversity of California, San Francisco · US

Funding

UCSF-GIVI CENTER FOR AIDS RESEARCHP30MH059037 · NIMH · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI JACOBSON, MARK A · 1998 to 2001
$4.9M
HIV CORECEPTORS--FUNCTION, SPECIFICITY AND PATHOGENESISR01AI043695 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI GOLDSMITH, MARK A · 1999 to 2001
$570k
ANALYSIS OF HIV VPR ACTION IN LYMPHOID HISTOCULTURESK08AI001866 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI SHERMAN, MICHAEL P · 2001 to 2002
$213k
NIAID NIH HHS K08 AI001866NIAID NIH HHS K08-AI01866NIAID NIH HHS R01-AI43695NIAID NIH HHS R01-AI45234NIMH NIH HHS P30-MH59037
6 · The paper itself

Abstract

Retroviruses must gain access to the host cell nucleus for subsequent replication and viral propagation. Human immunodeficiency virus type 1 (HIV-1) and other primate lentiviruses are distinguished from the gammaretroviruses by their ability to infect nondividing cells such as macrophages, an important viral reservoir in vivo. Rather than requiring nuclear membrane breakdown during cell division, the HIV-1 preintegration complex (PIC) enters the nucleus by traversing the central aqueous channel of the limiting nuclear pore complex. The HIV-1 PIC contains three nucleophilic proteins, matrix, integrase, and Vpr, all of which have been implicated in nuclear targeting. The mechanism by which Vpr can display such nucleophilic properties and yet also be available for incorporation into virions assembling at the plasma membrane is unresolved. We recently characterized Vpr as a nucleocytoplasmic shuttling protein that contains two novel nuclear import signals and an exportin-1-dependent nuclear export signal (NES). We now demonstrate that mutation of this NES impairs the incorporation of Vpr into newly formed virions. Furthermore, we find that the Vpr NES is required for efficient HIV replication in tissue macrophages present in human spleens and tonsils. These findings underscore how the nucleocytoplasmic shuttling of Vpr not only contributes to nuclear import of the HIV-1 PIC but also enables Vpr to be present in the cytoplasm for incorporation into virions, leading to enhancement of viral spread within nondividing tissue macrophages.

Indexed as

Active Transport, Cell NucleusVirus ReplicationCell LineCell NucleusG2 PhaseGene Products, vprHIV-1HumansLymphoid TissueMacrophagesProtein Transportvpr Gene Products, Human Immunodeficiency VirusGene Products, vprvpr Gene Products, Human Immunodeficiency Virus

Identifiers

PMID12805458
PMCPMC164827
OpenAlexW2055078115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.